Clinical Trials
62 trialsBYQoL-GC
Assistance Publique - Hôpitaux de Paris
Spotlight
Astellas Pharma Inc
CodeBreaK 301
Amgen
GLOW
Astellas Pharma Inc
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
SOLSTICE
Servier
COSMIC-312
Exelixis
IROCAS
UNICANCER
FIDURA
Sahlgrenska University Hospital
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Novartis
OSCAR
Federation Francophone de Cancerologie Digestive
Néofirinox
UNICANCER
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
LEO Pharma
OPTIMA
Imunon
ProMeLAR
Blokhin's Russian Cancer Research Center
PRECONNECT
Servier
GAMMA
NantCell, Inc.
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Surgimab
ASPIRIN
University Hospital, Antwerp
CanStem303C
Sumitomo Pharma America, Inc.
CanStem111P
Sumitomo Pharma America, Inc.
apact
Celgene
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
NuCana plc
GASVERT
Institut de Cancérologie de Lorraine
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Amgen
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Amgen
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Amgen
METRICS
Health Clinics Limited
ANGEL
Elevar Therapeutics
PATRON
Cellxpert Biotechnology Corp.
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
Eisai Inc.
POLAR-A
Egetis Therapeutics
POLAR-M
Egetis Therapeutics
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
PHOCUS
SillaJen, Inc.
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Canadian Cancer Trials Group
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma
Samsung Medical Center
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Amgen
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
Hellenic Oncology Research Group
Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.
Novartis
Neoimmune
Société des Produits Nestlé (SPN)
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection
Memorial Sloan Kettering Cancer Center
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
University of South Florida
PDT
Weill Medical College of Cornell University
SHARP
Bayer